跳至主要内容
临床试验/DRKS00014711
DRKS00014711已完成不适用

A post market clinical follow-up study with the short stem uncemented endoprosthesis (optimys )

Mathys Orthopädie GmbH0 个研究点目标入组 224 人开始时间: 2018年5月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
224

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 85 Years(—)
性别
All

入选标准

  • Patient shall:
  • suffer from primary or secondary coxarthrosis. One or more of the following pathologies/symptoms: coxarthrosis, dysplastic coxarthrosis, rheumatoid arthritis, necrosis of the head of the femur or posttraumatic coxarthrosis.
  • Be ready to participate in the follow-up examinations mentioned above
  • Be between 18 and 85 years old at the time of inclusion
  • Be a candidate for a primary implantation of a hip endoprosthesis
  • Be expected to recover completely
  • Additional inclusion criteria for sub-group:
  • Implantation of a RM Pressfit vitamys Cup
  • Unilateral THA with healthy contralateral hip
  • X-ray must be analyzable

排除标准

  • Patient may not:
  • Participate simultaneously in another clinical study or documentation with other orthopaedic implants of competitors.
  • Offer no guarantee for regular follow-up controls
  • Suffer from the exclusion criteria: sepsis or malignant tumours.
  • Have an ASA Classification > 3.
  • Have a revision surgery

研究者

相似试验